carboxyamido-triazole has been researched along with fumagillin in 1 studies
| Studies (carboxyamido-triazole) | Trials (carboxyamido-triazole) | Recent Studies (post-2010) (carboxyamido-triazole) | Studies (fumagillin) | Trials (fumagillin) | Recent Studies (post-2010) (fumagillin) |
|---|---|---|---|---|---|
| 105 | 15 | 22 | 326 | 5 | 68 |
| Protein | Taxonomy | carboxyamido-triazole (IC50) | fumagillin (IC50) |
|---|---|---|---|
| Methionine aminopeptidase 2 | Homo sapiens (human) | 0.0082 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Libutti, SK; Zogakis, TG | 1 |
1 review(s) available for carboxyamido-triazole and fumagillin
| Article | Year |
|---|---|
General aspects of anti-angiogenesis and cancer therapy.
Topics: Angiogenesis Inhibitors; Animals; Antibodies; Clinical Trials as Topic; Collagen; Cyclohexanes; Endostatins; Endothelial Growth Factors; Fatty Acids, Unsaturated; Humans; Interleukin-12; Lymphokines; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Neoplasms; O-(Chloroacetylcarbamoyl)fumagillol; Peptide Fragments; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Receptors, Vitronectin; RNA, Catalytic; Sesquiterpenes; Suramin; Thalidomide; Triazoles; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |